Induction of L1 and L2 β-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 4, 2008, Pages 1525-1528

  Okazaki, Aki ^a   Avison, Matthew B ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIAL ENZYME; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE L1; BETA LACTAMASE L2; CEFOTAXIME; CEFTAZIDIME; IMIPENEM; MEROPENEM; PIPERACILLIN; PROTEIN AMPR; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

AMPLICON; ARTICLE; BACTERIAL GENE; BACTERIAL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME SYNTHESIS; FRAMESHIFT MUTATION; GENE REPLACEMENT THERAPY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR BIOLOGY; MOLECULAR PHYLOGENY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATOR GENE; STENOTROPHOMONAS MALTOPHILIA; SUICIDE GENE; TRANSCRIPTION REGULATION;

BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; ENZYME INDUCTION; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REGULATOR; HUMANS; MUTATION; STENOTROPHOMONAS MALTOPHILIA;

EID: 42049088493     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01485-07     Document Type: Article

References (19)

1. Akova, M., G. Bonfiglio, and D. M. Livermore. 1991. Susceptibility to β-lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L1 and L2 β-lactamases. J. Med. Microbiol. 35:208-213.
2. Altschul, S. F., W. Gish, W. Miller, E. W. Meyers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
3. Andrews, J. M. 2001. Determining minimum inhibitory concentrations. J. Antimicrob. Chemother. 48(Suppl. 1):5-16.
4. Avison, M. B., P. Niumsup, T. R. Walsh, and P. M. Bennett. 2000. Aeromonas hydrophila AmpH and CepH β-lactamases: derepressed expression in mutants of Escherichia coli lacking CreB. J. Antimicrob. Chemother. 46:695-702.
5. Avison, M. B., C. J. von Heldreich, C. S. Higgins, P. M. Bennett, and T. R. Walsh. 2000. A TEM-2 β-lactamase encoded on an active Tn/-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 46:879-884.
6. Avison, M. B., C. S. Higgins, C. J. von Heldreich, P. M. Bennett, and T. R. Walsh. 2001. Plasmid location and molecular heterogeneity of the L1 and L2 β-lactamase genes of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 45:413-419.
7. Avison, M. B., C. S. Higgins, P. J. Ford, C. J. von Heldreich, T. R. Walsh, and P. M. Bennett. 2002. Differential regulation of L1 and L2 β-lactamase expression in Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 49:387-389.
8. Bagge, N., O. Ciofu, M. Hentzer, J. I. Campbell, M. Givskov, and N. Høiby. 2002. Constitutive high expression of chromosomal β-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS7669) located in ampD. Antimicrob. Agents Chemother. 46:3406-3411.
9. Denton, M., and K. G. Kerr. 1998. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin. Microbiol. Rev. 11:57-80.
10. Gould, V. C., A. Okazaki, R. A. Howe, and M. B. Avison. 2004. Analysis of sequence variation amongst smeDEF multi-drug efflux pump genes and flanking DNA from defined 16S rRNA sub-groups of clinical Stenotrophomonas maltophilia isolates. J. Antimicrob. Chemother. 54:348-353.
11. Gould, V. C., A. Okazaki, and M. B. Avison. 2006. β-Lactam resistance and β-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships. J. Antimicrob. Chemother. 57:199-203.
12. Gould, V. C., and M. B. Avison. 2006. SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships. J. Antimicrob. Chemother. 57:1070-1076.
13. Hanson, N. D., and C. C. Sanders. 1999. Regulation of inducible AmpC β-lactamase expression among Enterobacteriaceae. Curr. Pharm. Des. 5:881-894.
14. Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma, and H. P. Schweizer. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86.
15. Juan, C., B. Moyá, J. L. Pérez, and A. Oliver. 2006. Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level β-lactam resistance involves three AmpD homologues. Antimicrob. Agents Chemother. 50:1780-1787.
16. Kuga, A., R. Okamoto, and M. Inoue. 2000. ampR gene mutations that greatly increased AmpC β-lactamase activity in Enterobacter cloacae. Antimicrob. Agents Chemother. 44:561-567.
17. Niumsup, P., A. M. Simm, K. Nurmahomed, T. R. Walsh, P. M. Bennett, and M. B. Avison. 2003. Genetic linkage of the penicillinase gene, amp, and UrAB, encoding the regulator of β-lactamase expression in Aeromonas spp. J. Antimicrob. Chemother. 51:1351-1358.
18. Okazaki, A., and M. B. Avison. 2007. Aph(3′)-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 51:359-360.
19. Weng, S. F., J. W. Lin, C. H. Chen, Y. Y. Chen, Y. H. Tseng, and Y. H. Tseng. 2004. Constitutive expression of a chromosomal class A (BJM group 2) β-lactamase in Xanthomonas campestris. Antimicrob. Agents Chemother. 48:209-215.